Duopharma Biotech Berhad (KLSE:DPHARMA) investors are sitting on a loss of 42% if they invested three years ago
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that’s been the case for longer term Duopharma Biotech Berhad (KLSE:DPHARMA) shareholders, since the share price is down